AnitaSabichiMD

Oncology • Houston, TX

Genitourinary Oncology, Head & Neck Cancer, Hematologic Oncology, Thoracic Cancer

Assistant Professor, Hematology & Oncology, Baylor College of Medicine

Join to view full profile

Dr. Sabichi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Sabichi's full profile

Already have an account?

Office
6620 Main St
Houston, TX 77030
Phone+1 713-798-3750

Fax+1 713-798-3342
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1987 - 1990
University of Colorado School of Medicine Anschutz Medical CampusClass of 1987

Certifications & Licensure

NY State Medical License 1988 - 2026
TX State Medical License 1998 - 2024
MD State Medical License 1990 - 2017
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer Start of enrollment: 1998 Jul 30
Completed
Phase 3
Celecoxib in Treating Patients With Bladder Cancer Start of enrollment: 2000 Jun 01
Completed
Phase 2, Phase 3
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Start of enrollment: 2008 Aug 08
Active, not recruiting
Phase 3
Study of Metformin With Simvastatin for Men With Prostate Carcinoma Start of enrollment: 2012 Jan 01
Withdrawn
Phase 2
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
Terminated
Phase 1
Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01
Completed
Phase 2
Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01
Completed
Phase 2, Phase 3
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29
Active, not recruiting
Phase 3
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments Start of enrollment: 2019 Oct 01
Recruiting
Roles: Contact, Principal Investigator
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers Start of enrollment: 2021 Aug 31
Recruiting
Phase 2
Roles: Contact
Evaluation of Response to Abiraterone/Prednisone by Race/Ethnicity and Other Factors in Metastatic Hormone Naive Prostate Cancer Start of enrollment: 2019 May 23
Recruiting
Phase 2
Roles: Contact
Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC Start of enrollment: 2024 Apr 09
Not yet recruiting
Phase 1, Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
Jan O Kemnade, Marcus Florez, Anita Sabichi, Jun Zhang, Pavan Jhaveri, George Chen, Albert Chen, Courtney Miller-Chism, Bulsara Shaun, Susan G Hilsenbeck, David J Hern...> ;Oral Oncology. 2023 Oct 1
Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes.
Ola Soliman, David C Wilde, Jan O Kemnade, Anita L Sabichi, George Chen, Albert Chen, Samantha N Little, Andrew T Huang, David J Hernandez, Vlad C Sandulache> ;Laryngoscope Investigative Otolaryngology. 2023 Aug 1
8 citations
Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access.
Marcus A Florez, Jan O Kemnade, Nan Chen, Wendy Du, Anita L Sabichi, Daniel Y Wang, Quillan Huang, Courtney N Miller-Chism, Aparna Jotwani, Albert C Chen, David Hernan...> ;Cancer Research Communications. 2022 Jul 26
2 citations
Non-small cell lung cancer in the era of immunotherapy.
Quillan Huang, Jan Kemnade, Loraine Cornwell, Farrah Kheradmand, Anita L Sabichi, Devika Das> ;Seminars in Oncology. 2022 Jul 8
68 citations
Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update
Jessica P. Hwang, Jordan J. Feld, Sarah P. Hammond, Devena E. Alston-Johnson, Donna R. Cryer, Dawn L. Hershman, Andrew P. Loehrer, Anita L. Sabichi, Banu Symington, No...> ;Journal of Clinical Oncology. 2020 Jul 27
4 citations
Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.
Vlad C. Sandulache, Yu Lei, Lynn E. Heasley, M. Chang, C.I. Amos, Erich M. Sturgis, Evan M. Graboyes, Elizabeth Y. Chiao, N. Rogus-Pulia, James S. Lewis, Anant Madabhu...> ;Oral Oncology. 2020 Mar 1
11 citations
Predictors of benefits from frontline chemoimmunotherapy in stage IV non-small-cell lung cancer: a meta-analysis
Hazem E El-Osta, Frank E. Mott, Bryan M. Burt, Daniel Y. Wang, Anita L. Sabichi> ;Oncoimmunology. 2019 Sep 20
7 citations
Primary Spinal Cord Melanoma - An Uncommon Entity.
Ritodhi Chatterjee, Fábio A. Nascimento, Kent A. Heck, Alexander E. Ropper, Anita L. Sabichi> ;The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 2019 May 1
23 citations
Nivolumab Treatment for Cancers in the HIV-infected Population.
Elaine Chang, Anita L. Sabichi, Jennifer R. Kramer, Christine Hartman, Kathryn E. Royse, Donna L. White, Niraj R. Patel, Peter Richardson, Sarvari Venkata Yellapragada...> ;Journal of Immunotherapy. 2018 Oct 1
9 citations
Treatment Patterns in Veterans with Laryngeal and Oropharyngeal Cancer and Impact on Survival
Peter Richardson, Sagar Kansara, George G. Chen, Anita L. Sabichi, Andrew G. Sikora, Robert B. Parke, Donald T. Donovan, Elizabeth Y. Chiao, Vlad C. Sandulache> ;Laryngoscope Investigative Otolaryngology. 2018 Aug 1
38 citations
Myasthenia Gravis After Nivolumab Therapy for Squamous Cell Carcinoma of the Bladder.
Elaine Chang, Anita L Sabichi, Yvonne H Sada> ;Journal of Immunotherapy. 2017 Apr 1
Reply to J. Cabezas et al
Jessica P. Hwang, Mark R. Somerfield, Devena E. Alston-Johnson, Donna R. Cryer, Jordan J. Feld, Barnett S. Kramer, Anita L. Sabichi, Sandra L. Wong, Andrew S. Artz> ;Journal of Clinical Oncology. 2016 Jan 20
128 citations
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
Jessica P. Hwang, Mark R. Somerfield, Devena E. Alston-Johnson, Donna R. Cryer, Jordan J. Feld, Barnett S. Kramer, Anita L. Sabichi, Sandra L. Wong, Andrew S. Artz> ;Journal of Clinical Oncology. 2015 Jul 1
35 citations
HuR Suppresses Fas Expression and Correlates with Patient Outcome in Liver Cancer.
Haifeng Zhu, Zuzana Berkova, Rohit Mathur, Lalit Sehgal, Tamer Khashab, Rong-Hua Tao, Xue Ao, Lei Feng, Anita L. Sabichi, Boris Blechacz, Asif Rashid, Felipe Samaniego> ;Molecular Cancer Research. 2015 May 1
58 citations
Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex
Jillian F. Wise, Zuzana Berkova, Rohit Mathur, Haifeng Zhu, Frank K. Braun, Rong-Hua Tao, Anita L. Sabichi, Xue Ao, Hoyoung Maeng, Felipe Samaniego> ;Blood. 2013 Jun 6
26 citations
Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.
Tarek El-Sawy, Anita L. Sabichi, Jeffrey N. Myers, Merrill S. Kies, William N. William, Bonnie S. Glisson, Scott M. Lippman, Bita Esmaeli> ;Archives of Ophthalmology. 2012 Dec 1
863 citations
Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review
Peter B. Bach, Joshua N. Mirkin, Thomas K. Oliver, Christopher G. Azzoli, Donald A. Berry, Otis W. Brawley, Tim Byers, Graham A. Colditz, Michael K. Gould, James R. Je...> ;JAMA. 2012 Jun 13
39 citations
A Randomized Controlled Trial of Celecoxib to Prevent Recurrence of Nonmuscle-Invasive Bladder Cancer
Anita L. Sabichi, J. Jack Lee, H. Barton Grossman, Suyu Liu, Ellen Richmond, Bogdan Czerniak, Jorge De La Cerda, Craig J. Eagle, Jaye L. Viner, J. Lynn Palmer, Seth P....> ;Cancer Prevention Research. 2011 Oct 1
Randomized trial of a short course of erlotinib 150 to 300 mg daily prior to surgery for squamous cell carcinomas of the head and neck (SCCHN) in current, former, and ...
William Junior WN, Weber RS, Lee JJ, Myers J, Ginsberg LE, El-Naggar AK, Sturgis EM, Sabichi AL, Kies MS, Hanna EY, Hessel AC, Lu C, Lai SY, Ayuste R, Lippman SM, Kim ES> ;J. Clin. Oncol.. 2011-05-20
4 citations
System Level Changes in Gene Expression in Maturing Bladder Mucosa
Mikhail G. Dozmorov, Randolph Stone, John L. Clifford, Anita L. Sabichi, C. Dirk Engles, Paul J. Hauser, Daniel J. Culkin, Robert E. Hurst> ;The Journal of Urology. 2011 May 1
54 citations
Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
Edmund Chiong, I-Ling Lee, Ali Dadbin, Anita L. Sabichi, Loleta D. Harris, Diana L. Urbauer, David J. McConkey, Rian J. Dickstein, Tiewei Cheng, H. Barton Grossman> ;Clinical Cancer Research. 2011 May 1
136 citations
American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Trea...
Andrew S. Artz, Mark R. Somerfield, Jordan J. Feld, Andrew F. Giusti, Barnett S. Kramer, Anita L. Sabichi, Robin Zon, Sandra L. Wong> ;Journal of Clinical Oncology. 2010 Jul 1
18 citations
Identification of genes correlated with early-stage bladder cancer progression.
Randolph Stone, Anita L. Sabichi, Jennifer N Gill, I-Ling Lee, Patrick Adegboyega, Michael S. Dai, Raja Loganantharaj, Marjan Trutschl, Urska Cvek, John L. Clifford> ;Cancer Prevention Research. 2010 Jun 1
8 citations
Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
J. Jack Lee, Lei Feng, Daniel S. Reshef, Anita L. Sabichi, Brendell Williams, Waree Rinsurongkawong, Ignacio I. Wistuba, Reuben Lotan, Scott M. Lippman> ;Cancer Prevention Research. 2010 Jun 1
40 citations
Three synchronous HPV-associated squamous cell carcinomas of Waldeyer's ring: case report and comparison with Slaughter's model of field cancerization.
Susan L. McGovern, Michelle D. Williams, Randal S. Weber, Anita L. Sabichi, Mark S. Chambers, Jack W. Martin, K.S.Clifford Chao> ;Head & Neck. 2009 Jul 1
Join now to see all